Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 10, 1996

View Archived Issues

GRF analogs under study at Tulane University

Benzothiophene compounds for women's health disclosed by Lilly

Merck & Co. reveals new agents for BPH

New antiinflammatory agents disclosed by DuPont Merck

Sugen reports antihyperproliferative agents

Merck Frosst's apopain inhibitors: A novel approach to multiple disorders

New neuroleptic agents reported by Ferrer

Japanese academic researchers isolate new quassinoid compound

Avitar's collection system marketed for DNA testing

U.S. market introduction for novel antifungal formulation

HemispheRx CFS diagnostic receives European patent approval

Roberts in-licenses another GI drug from Lilly

BMS reports results from cefprozil multicenter clinical study in AOM patients

P&U anticipates filing for urinary incontinence treatment soon

FDA approves new agent for spasticity

FemPatch approved for marketing in U.S.

CytRx subsidiary to merge with Zynaxis

Paracetamol safety established in pregnant mothers and their babies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 2, 2025.
Unnatural Products joins Argenx in a $1.5B macrocyclic deal
BioWorld
Unnatural Products Inc. notched another collaboration by signing on with Argenx SE in a multitarget research collaboration. Unnatural Products, which is getting...
Exercise-mimicking compound offers alternative to GLP-1 therapies
BioWorld
An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
CMS eyes competitive bidding for CGMs, insulin pumps
BioWorld MedTech
The U.S. Centers for Medicare & Medicaid Services posted the draft home health rule for calendar year 2026, which includes a proposal to subject continuous...